Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin ( ) receptor?
- 1 January 1997
- journal article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 18, 189-194
- https://doi.org/10.1016/s0098-2997(97)00012-5
Abstract
No abstract availableKeywords
Funding Information
- School of Medicine, University of Maryland (02390510)
- Nordic Pharma Group
- Medtronic
This publication has 7 references indexed in Scilit:
- Hemostatic Changes After Dietary Coenzyme Q10 Supplementation in SwineJournal of Cardiovascular Pharmacology, 1996
- Tetrafibricin Has a High Selectivity for GPIIb/IIIa: Comparison of the Effects of Tetrafibricin and RGDS on GPIIb/IIIa and the Vitronectin ReceptorBiochemical and Biophysical Research Communications, 1994
- Perspectives on therapy of cardiovascular diseases with oenzyme Q10 (Ubiquinone)Journal of Molecular Medicine, 1993
- Structure and Biological Role of VitronectinAnnual Review of Cell Biology, 1991
- Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen.Circulation Research, 1990
- Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Organic structural specificity of coenzyme Q for biological activityBiochemical and Biophysical Research Communications, 1966